A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

AIMS: We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. METHODS: Using nationwide registries (Norwegian Patient Registry and Norwegian Prescription Database), we identified A...

Descripción completa

Detalles Bibliográficos
Autores principales: Halvorsen, Sigrun, Ghanima, Waleed, Fride Tvete, Ingunn, Hoxmark, Cecilie, Falck, Pål, Solli, Oddvar, Jonasson, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216196/
https://www.ncbi.nlm.nih.gov/pubmed/27680880
http://dx.doi.org/10.1093/ehjcvp/pvw031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216196/
https://www.ncbi.nlm.nih.gov/pubmed/27680880
http://dx.doi.org/10.1093/ehjcvp/pvw031

Ejemplares similares